Call Us
267 354 2894
Frequently Asked
Questions
Frequently Asked
Questions
TMS (transcranial magnetic stimulation)
Nurowav TMS powered by NeuroStar tecnology is a non-drug, non-invasive therapy that can help you achieve long-term relief from the symptoms of depression. Many people’s depression symptoms significantly improve or go away after 4 to 6 weeks of treatment. In clinical studies, NeuroStar has shown to provide acute treatment response and remission for over one year.*
An FDA-cleared depression treatment, TMS therapy is safe and easy to tolerate.** Because it’s non-drug and non-invasive, it does not have the common systemic side effects of medication. NeuroStar does not have any effects on cognition or sleep. The most common side effect associated is mild to moderate pain or discomfort that typically subsides within the first week of treatment.
NeuroStar TMS has been systematically evaluated for its effects on memory. These clinical trials demonstrated that TMS therapy does not result in any adverse effects on memory or concentration.***
During the session, you will feel a tapping sensation on your head. Each treatment session lasts around 19 minutes. Some patients experience mild to moderate pain or discomfort at or near the treatment site during the first week of treatment. This is usually temporary and subsides in subsequent treatments.
TMS therapy is not experimental; it was cleared by the FDA in 2008 to help people fight depression and in 2022 for decreasing anxiety symptoms in adult patients suffering from major depressive disorder and as an adjunct therapy for adults with OCD. Nurowav TMS uses the NeuroStar unit - the top TMS choice of doctors, and over 6.6 million treatments have been delivered.
SPRAVATO® (nasal esketamine)
SPRAVATO® (esketamine) CIII nasal spray is a derivative of ketamine. SPRAVATO® is an FDA-approved nasal spray for treatment-resistant depression; it is also approved to treat depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions. Ketamine has not been approved by the FDA to treat depression.
You cannot take SPRAVATO® on your own. You will administer SPRAVATO® nasal spray yourself under the supervision of a healthcare provider, at a certified SPRAVATO® treatment center. You can choose the location that works best for you; ask your healthcare provider to help find a location. SPRAVATO® cannot be purchased at a pharmacy. Because of the risks for sedation or loss of consciousness, dissociation, respiratory depression, and abuse and misuse, SPRAVATO® can only be administered at healthcare settings certified in the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program.
No, treatment with SPRAVATO® is not recommended during pregnancy or while breastfeeding. SPRAVATO® may harm your baby. You should let your healthcare provider know if you are pregnant, planning to become pregnant, breastfeeding or planning to breastfeed. If you are a woman planning to start SPRAVATO®, and are of childbearing age, you should use highly effective contraception while taking SPRAVATO®. Talk with your healthcare provider about methods of birth control that should be used.
If you have high blood pressure, whether treated or not, you should discuss that specifically with your healthcare provider in deciding whether SPRAVATO® may be right for you. Do not take SPRAVATO® if you have a blood vessel disease (aneurysm), an abnormal connection between your blood vessels (arteriovenous malformation) or a history of bleeding in the brain.
SPRAVATO® can increase your blood pressure temporarily – for about four hours – so you will have your blood pressure measured at various times, including before and after taking SPRAVATO®.
If your blood pressure is high before using this medicine, your healthcare provider will decide whether to start the medicine or wait until your blood pressure is lower.
Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision or seizures after taking SPRAVATO®.
Some patients taking SPRAVATO® may experience nausea or vomiting. Because of this, you should avoid eating two hours before, and drinking liquids 30 minutes before, taking SPRAVATO®.
You should discuss your plans for the remainder of the day with your healthcare provider. Because of possible side effects affecting mental alertness and motor coordination, you won’t be able to drive, operate machinery or do anything where you need to be completely alert until the day after a treatment session, following a restful sleep, even if you think you feel well enough to do so. Because of this driving restriction, you will need to plan for your rides on treatment days.
Medication Management
Medication management is the process of prescribing, monitoring, and adjusting medications for mental health disorders.
Psychiatric medication can benefit those struggling with anxiety, depression, bipolar disorder, OCD, schizophrenia, PTSD, ADHD, and OCD, or those struggling with life changes or emotional distress.
First you will have an assessment with a Nurowav TMS Psychiatric Nurse Practitioner to discuss your symptoms and decide which medications may be right for you. Our PNP will go over how the medication works, potential side effects and what outcome is to be expected. You be scheduled follow-up visits so your progress can be monitored, as well as to look for side effects or the need for any necessary adjustments.
The length of time it takes to see medication results varies. Some medication works quickly while others can take days or weeks for the patient to begin seeing results. Your PNP will discuss what you can expect based on your medication and dose given.
still have questions?
Give us a call at 267-354-2894 or schedule your free consultation online now